{
    "2018-03-25": [
        [
            {
                "time": "",
                "original_text": "生物药“独角兽”复宏汉霖总裁刘世高：中国药物研发处在百年难得一见的机遇期",
                "features": {
                    "keywords": [
                        "生物药",
                        "独角兽",
                        "复宏汉霖",
                        "刘世高",
                        "中国",
                        "药物研发",
                        "机遇期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药龙头“复星医药”还有机会上车吗？",
                "features": {
                    "keywords": [
                        "医药",
                        "龙头",
                        "复星医药",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}